Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
Public ClinicalTrials.gov record NCT00759135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Multicenter Randomized Two Dose Level and Non-Inferiority Clinical Evaluation of Transrectal Administration of NX-1207 for the Treatment of BPH
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This completed study evaluated the safety and efficacy of two dose levels of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) versus finasteride.
Study identification
- NCT ID
- NCT00759135
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 85 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 45 Years to 75 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Jan 2008 (Actual)
- Completion
- May 2008 (Actual)
- Last update posted
- Jun 14, 2012
2007 – 2008
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nymox Investigational Site | Huntsville | Alabama | — | — |
| Nymox Investigational Site | Tucson | Arizona | — | — |
| Nymox Investigational Site | Little Rock | Arkansas | — | — |
| Nymox Investigational Site | Anaheim | California | — | — |
| Nymox Investigational Site | Atherton | California | — | — |
| Nymox Investigational Site | Long Beach | California | — | — |
| Nymox Investigational Site | Modesto | California | — | — |
| Nymox Investigational Site | Newport Beach | California | — | — |
| Nymox Investigational Site | Denver | Colorado | — | — |
| Nymox Investigational Site | New Britain | Connecticut | — | — |
| Nymox Investigational Site | Sarasota | Florida | — | — |
| Nymox Investigational Site | Greenwood | Indiana | — | — |
| Nymox Investigational Site | Jeffersonville | Indiana | — | — |
| Nymox Investigational Site | Shreveport | Louisiana | — | — |
| Nymox Investigational Site | Missoula | Montana | — | — |
| Nymox Investigational Site | Las Vegas | Nevada | — | — |
| Nymox Investigational Site | Lawrenceville | New Jersey | — | — |
| Nymox Investigational Site | Marlton | New Jersey | — | — |
| Nymox Investigational Site | Voorhees Township | New Jersey | — | — |
| Nymox Investigational Site | Garden City | New York | — | — |
| Nymox Investigational Site | Poughkeepsie | New York | — | — |
| Nymox Investigational Site | Staten Island | New York | — | — |
| Nymox Investigational Site | Lancaster | Pennsylvania | — | — |
| Nymox Investigational Site | Myrtle Beach | South Carolina | — | — |
| Nymox Investigational Site | Germantown | Tennessee | — | — |
| Nymox Investigational Site | Arlington | Texas | — | — |
| Nymox Investigational Site | Brownsville | Texas | — | — |
| Nymox Investigational Site | Dallas | Texas | — | — |
| Nymox Investigational Site | McAllen | Texas | — | — |
| Nymox Investigational Site | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00759135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2012 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00759135 live on ClinicalTrials.gov.